We define the defenses mounted by the virus to shield its V3-glycan epitope during infection and demonstrate how the DH270 clone developed to first engage Env and then matured to effectively circumvent these barriers to achieve neutralization breadth. The gene discussed is ERVW-1; the disease is infection.